Member Contact: Brett Carter
Position: Chief Executive Officer
Industry: Academic Research Organisations
Cancer Therapeutics CRC (CTx) brings together Australia's expertise in cancer biology, translational oncology and drug discovery and links them to world-renowned expertise in the commercialisation of new cancer therapeutics.
The primary outcome of CTx will be the discovery and development of new cancer drug candidates. CTx engages broadly with public sector research organisations and Australian SMEs focused on oncology. It has established a unique and productive training environment for Australia's growing pharmaceutical industry.
CTx is developing a diverse pipeline of novel cancer drug candidates ready for clinical testing and to benefit patients both in Australia and worldwide. The most advanced programs in this pipeline will be ready for commercialisation in 2011/2012.